Human Health

Drug Discovery

Target/therapeutic interaction and genomic studies

Gaining structural insights through NMR

As part of the drug discovery process, determining the binding site interaction between the protein target and potential small molecule or biotherapeutic is of critical importance.

The tools and expertise required to produce this data are specialized and very expensive to build and maintain in-house.

Eremid™ has both the expertise and Nuclear Magnetic Resonance (NMR) capability to accelerate your drug discovery process. We are able to directly observe target proteins and potential therapeutics, investigating their interactions and structural relationships in solution, and mapping binding sites. We can then support you in improving the kinetic properties of promising ligands through design.

Better drug discovery through genomics

Understanding the cause and effect of disease at the molecular and physiological level supports the identification of better potential drug targets.  A huge percentage of potential drugs never reach patients because there is not enough understanding of the drug target, and the disease to be treated.

Eremids’ team has the experience and the tools to advance candidate identification and characterization through both pharmacogenomics (sequencing, statistical genetics, gene expression), and pharmacometabolomics (metabolomics signatures, global panel discovery).

Looking for deeper insights on your next project?

Discuss a project
Looking for deeper insights on your next project? Discuss a project
"Working with Eremid has been a pleasure. We received excellent data with a very fast turnaround and appreciated the attentive and helpful project management!" Steve Watkins, BCD Biosciences, CA USA — CEO